• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于过氧化物酶体增殖物激活受体激动剂增强ABCA1基因表达的机制。

On the mechanism for PPAR agonists to enhance ABCA1 gene expression.

作者信息

Ogata Masaki, Tsujita Maki, Hossain Mohammad Anwar, Akita Nobukatsu, Gonzalez Frank J, Staels Bart, Suzuki Shogo, Fukutomi Tatsuya, Kimura Genjiro, Yokoyama Shinji

机构信息

Nagoya City University Graduate School of Medical Sciences, Japan.

出版信息

Atherosclerosis. 2009 Aug;205(2):413-9. doi: 10.1016/j.atherosclerosis.2009.01.008. Epub 2009 Jan 19.

DOI:10.1016/j.atherosclerosis.2009.01.008
PMID:19201410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2790138/
Abstract

Expression of ATP binding cassette transporter A1 (ABCA1), a major regulator of high density lipoprotein (HDL) biogenesis, is known to be up-regulated by the transcription factor liver X receptor (LXR) alpha, and expression is further enhanced by activation of the peroxisome proliferator activated receptors (PPARs). We investigated this complex regulatory network using specific PPAR agonists: four fibrates (fenofibrate, bezafibrate, gemfibrozil and LY518674), a PPAR delta agonist (GW501516) and a PPAR gamma agonist (pioglitazone). All of these compounds increased the expression of LXRs, PPARs and ABCA1 mRNAs, and associated apoA-I-mediated lipid release in THP-1 macrophage, WI38 fibroblast and mouse fibroblast. When mouse fibroblasts lacking expression of PPAR alpha were examined, the effects of fenofibrate and LY518674 were markedly diminished while induction by other ligands were retained. The PPAR alpha promoter was activated by all of these compounds in an LXR alpha-dependent manner, and partially in a PPAR alpha-dependent manner, in mouse fibroblast. The LXR responsive element (LXRE)-luciferase activity was enhanced by all the compounds in an LXR alpha-dependent manner in mouse fibroblast. This activation was exclusively PPAR alpha-dependent by fenofibrate and LY518674, but nonexclusively by the others. We conclude that PPARs and LXRs are involved in the regulation of ABCA1 expression and HDL biogenesis in a cooperative signal transduction pathway.

摘要

ATP结合盒转运蛋白A1(ABCA1)是高密度脂蛋白(HDL)生物合成的主要调节因子,已知其表达受转录因子肝X受体(LXR)α上调,而过氧化物酶体增殖物激活受体(PPARs)的激活可进一步增强其表达。我们使用特异性PPAR激动剂研究了这一复杂的调控网络:四种贝特类药物(非诺贝特、苯扎贝特、吉非贝齐和LY518674)、一种PPARδ激动剂(GW501516)和一种PPARγ激动剂(吡格列酮)。所有这些化合物均增加了THP-1巨噬细胞、WI38成纤维细胞和小鼠成纤维细胞中LXRs、PPARs和ABCA1 mRNA的表达以及载脂蛋白A-I介导的脂质释放。当检测缺乏PPARα表达的小鼠成纤维细胞时,非诺贝特和LY518674的作用明显减弱,而其他配体的诱导作用得以保留。在小鼠成纤维细胞中,所有这些化合物均以LXRα依赖的方式激活PPARα启动子,部分以PPARα依赖的方式激活。在小鼠成纤维细胞中,所有化合物均以LXRα依赖的方式增强LXR反应元件(LXRE)-荧光素酶活性。非诺贝特和LY518674对这种激活是完全PPARα依赖的,而其他化合物则不是。我们得出结论,PPARs和LXRs在协同信号转导途径中参与ABCA1表达和HDL生物合成的调控。

相似文献

1
On the mechanism for PPAR agonists to enhance ABCA1 gene expression.关于过氧化物酶体增殖物激活受体激动剂增强ABCA1基因表达的机制。
Atherosclerosis. 2009 Aug;205(2):413-9. doi: 10.1016/j.atherosclerosis.2009.01.008. Epub 2009 Jan 19.
2
Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes.贝特类药物对肝细胞中ABCA1表达及高密度脂蛋白生物合成的影响。
J Cardiovasc Pharmacol. 2008 Mar;51(3):258-66. doi: 10.1097/FJC.0b013e3181624b22.
3
Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells.合成肝X受体和过氧化物酶体增殖物激活受体激动剂对极化脑血管内皮细胞中固醇转运途径的调节作用。
Int J Biochem Cell Biol. 2006;38(8):1314-29. doi: 10.1016/j.biocel.2006.01.013. Epub 2006 Feb 24.
4
Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.吡格列酮通过 PPARγ/LXRα 通路增加 ABCA1/ABCG1 的表达从而增强巨噬细胞胆固醇外流:来自体外和体内研究的发现。
Atherosclerosis. 2011 Nov;219(1):141-50. doi: 10.1016/j.atherosclerosis.2011.07.113. Epub 2011 Aug 4.
5
The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.视黄酸X受体(RXR)激动剂PA024和HX630在巨噬细胞系中激活肝X受体(LXR)/视黄酸X受体(RXR)以及诱导ATP结合盒转运体A1(ABCA1)表达的能力不同。
Biochem Pharmacol. 2008 Oct 15;76(8):1006-13. doi: 10.1016/j.bcp.2008.08.005. Epub 2008 Aug 12.
6
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.过氧化物酶体增殖物激活受体(PPAR)α与肝脏X受体(LXR)在脂肪酸代谢营养调控中的相互作用。II. LXRs通过抑制PPAR信号传导抑制脂质降解基因启动子。
Mol Endocrinol. 2003 Jul;17(7):1255-67. doi: 10.1210/me.2002-0191. Epub 2003 May 1.
7
Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.山姜素增强胆固醇流出并抑制氧化型低密度脂蛋白负载的人巨噬细胞中的脂质积累。
Biotechnol Appl Biochem. 2015 Nov-Dec;62(6):840-7. doi: 10.1002/bab.1328. Epub 2015 May 17.
8
Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.非诺贝特与吡格列酮:PPAR-α和PPAR-γ激动剂对大鼠佐剂性关节炎抗关节炎效力的比较研究
Biomed Mater Eng. 2014;24(1 Suppl):81-8. doi: 10.3233/BME-140977.
9
Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages.磷脂酶 A2 组 IIA 与循环高密度脂蛋白胆固醇相关,并通过调节巨噬细胞中的 PPAR-γ/LXR-α/ABCA1 可能调节胆固醇流出。
J Transl Med. 2021 Nov 27;19(1):484. doi: 10.1186/s12967-021-03151-3.
10
Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner.非诺贝特酸是一种活性形式的非诺贝特,它通过以肝脏X受体依赖的方式增强ATP结合盒转运体A1基因的转录,增加载脂蛋白A-I介导的高密度脂蛋白生物合成。
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1193-7. doi: 10.1161/01.ATV.0000163844.07815.c4. Epub 2005 Mar 24.

引用本文的文献

1
The drug resistance feature of acute myeloid leukemia is related to the cell stiffness.急性髓系白血病的耐药特性与细胞硬度有关。
Biophys Rev (Melville). 2025 Jun 25;6(2):021402. doi: 10.1063/5.0244619. eCollection 2025 Jun.
2
Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis.揭示ATP结合盒(ABC)转运蛋白在胰岛素抵抗诱导的淀粉样蛋白生成中的新机制。
Metab Brain Dis. 2025 Jun 7;40(5):218. doi: 10.1007/s11011-025-01642-6.
3
PPAR affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium.过氧化物酶体增殖物激活受体(PPAR)通过干扰肠上皮细胞中的坏死性凋亡信号来影响肝脏脂质稳态。
Acta Pharm Sin B. 2024 Nov;14(11):4858-4873. doi: 10.1016/j.apsb.2024.08.021. Epub 2024 Aug 30.
4
Unraveling the Pleiotropic Role of High-Density Lipoproteins (HDLs) in Autoimmune Rheumatic Diseases.揭示高密度脂蛋白(HDL)在自身免疫性风湿性疾病中的多效性作用
Int J Rheumatol. 2024 Nov 14;2024:1896817. doi: 10.1155/2024/1896817. eCollection 2024.
5
PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets.动脉粥样硬化中的过氧化物酶体增殖物激活受体:从机制到可成药靶点的时空特征
J Adv Res. 2025 Mar;69:225-244. doi: 10.1016/j.jare.2024.03.020. Epub 2024 Mar 29.
6
Reexamining the Causes and Effects of Cholesterol Deposition in the Brains of Patients with Alzheimer's Disease.重新审视阿尔茨海默病患者大脑中胆固醇沉积的原因和影响。
Mol Neurobiol. 2023 Dec;60(12):6852-6868. doi: 10.1007/s12035-023-03529-y. Epub 2023 Jul 28.
7
Sichuan dark tea improves lipid metabolism and prevents aortic lipid deposition in diet-induced atherosclerosis model rats.四川黑茶改善饮食诱导的动脉粥样硬化模型大鼠的脂质代谢并预防主动脉脂质沉积。
Front Nutr. 2022 Nov 24;9:1014883. doi: 10.3389/fnut.2022.1014883. eCollection 2022.
8
Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner.胰岛素以 FOXO1 和 LXR 依赖的方式下调人肝癌细胞系 HepG2 中 ATP 结合盒转运蛋白 A-I 的表达。
Cell Biochem Biophys. 2023 Mar;81(1):151-160. doi: 10.1007/s12013-022-01109-w. Epub 2022 Oct 17.
9
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression.靶向三磷酸腺苷结合盒转运体 A1(ABCA1)基因表达的潜在治疗药物。
Drugs. 2022 Jul;82(10):1055-1075. doi: 10.1007/s40265-022-01743-x. Epub 2022 Jul 21.
10
PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.过氧化物酶体增殖物激活受体-α激动剂非诺贝特通过调节 NOD 小鼠 Th1/Th17 和 Treg 细胞反应改善干燥综合征样泪腺炎。
Invest Ophthalmol Vis Sci. 2022 Jun 1;63(6):12. doi: 10.1167/iovs.63.6.12.

本文引用的文献

1
Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.贝特类药物及未来的过氧化物酶体增殖物激活受体α激动剂在心血管疾病治疗中的应用
Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):542-53. doi: 10.1038/ncpcardio1278. Epub 2008 Jul 15.
2
ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation.载脂蛋白A-I通过抑制细胞内降解促进ABCA1循环/积累至细胞表面,并增加高密度脂蛋白的生成。
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1820-4. doi: 10.1161/ATVBAHA.108.169482. Epub 2008 Jul 10.
3
PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine.在小肠中,过氧化物酶体增殖物激活受体α(PPARα)基因表达受肝脏X受体(LXR)和孕烷X受体(PXR)激活剂上调。
Biochem Biophys Res Commun. 2008 Jul 11;371(4):675-8. doi: 10.1016/j.bbrc.2008.04.100. Epub 2008 Apr 28.
4
Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes.贝特类药物对肝细胞中ABCA1表达及高密度脂蛋白生物合成的影响。
J Cardiovasc Pharmacol. 2008 Mar;51(3):258-66. doi: 10.1097/FJC.0b013e3181624b22.
5
Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.胆固醇流出途径及其他参与高密度脂蛋白抗动脉粥样硬化作用的潜在机制。
J Intern Med. 2008 Mar;263(3):256-73. doi: 10.1111/j.1365-2796.2007.01898.x.
6
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?贝特类药物在代谢综合征血脂异常管理中是否有作用?
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):39-46. doi: 10.1161/ATVBAHA.107.148817. Epub 2007 Aug 23.
7
Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.过氧化物酶体增殖物激活受体δ激动剂给药后对健康受试者甘油三酯与高密度脂蛋白胆固醇的影响
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):359-65. doi: 10.1161/01.ATV.0000252790.70572.0c. Epub 2006 Nov 16.
8
Assembly of high-density lipoprotein.高密度脂蛋白的组装
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):20-7. doi: 10.1161/01.ATV.0000195789.39418.e8. Epub 2005 Nov 10.
9
Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner.非诺贝特酸是一种活性形式的非诺贝特,它通过以肝脏X受体依赖的方式增强ATP结合盒转运体A1基因的转录,增加载脂蛋白A-I介导的高密度脂蛋白生物合成。
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1193-7. doi: 10.1161/01.ATV.0000163844.07815.c4. Epub 2005 Mar 24.
10
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.过氧化物酶体增殖物激活受体α、β/δ和γ对小鼠巨噬细胞泡沫细胞形成及动脉粥样硬化的差异性抑制作用
J Clin Invest. 2004 Dec;114(11):1564-76. doi: 10.1172/JCI18730.